Moreover, it has been demonstrated that enhanced kinase activity of BCR-ABL and altered expression of Notch1 synergises to induce acute leukaemia in a transgenic model for CML [32]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.